Recently, US pharmaceutical giant Abbott announced their acquisition of Alere Inc at the price of $56 per share, spending a total of $5.8 billion. Through this transaction, Abbott will become the market leader in the industry of quick medical test. Recently US medical industry is accelerating its integration, now Abbott added a case of acquisitions.

On Monday Abbott’s chief executive officer Miles White disclosed to investors that, this transaction will enable the company’s diagnostics sales to increase to $70 billion. What’s more, Abbott’s genes mutation testing products will be added with new testing products for heart attack, cold and drug abuse. These products are able to assess patient's response to drugs, in order to guide cancer treatment.

According to Miles White, the need for quick test is accelerating, hospitals and consumers are looking for better ways to get fast, accurate and effective information to improve patient care and reduce unnecessary medical expenses.

The United States medical device industry has been integrating in the face of pressure from hospitals and medical system’s need for reducing costs. According to statistics, last year, the United States medical device industry had 1007 completed or uncompleted mergers and acquisitions, the total amount reached $58.9 billion.

On Monday there are another two M & A transactions. Artificial hip and knee leader Corp Stryker agreed to purchase Sage Products LLC from private company Madison Dearborn Partners. Medtronic, the world's largest maker of heart rate devices, agreed to acquire kidney dialysis equipment company Bellco. The transaction price is not yet disclosed.